A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder (2011)
- Authors:
- USP affiliated authors: PEREIRA, CARLOS ALBERTO DE BRAGANCA - IME ; MIGUEL FILHO, EURIPEDES CONSTANTINO - FM ; FOSSALUZA, VICTOR - IME
- Unidades: IME; FM
- DOI: 10.1097/JCP.0b013e3182367aee
- Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA); CO-TERAPIA; FÁRMACOS SINTÉTICOS; ANTIPSICÓTICOS
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2011
- Source:
- Título do periódico: Journal of Clinical Psychopharmacology
- ISSN: 0271-0749
- Volume/Número/Paginação/Ano: v. 31, n. 6, p. 763-768, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DINIZ, Juliana Belo et al. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, v. 31, n. 6, p. 763-768, 2011Tradução . . Disponível em: https://doi.org/10.1097/JCP.0b013e3182367aee. Acesso em: 19 abr. 2024. -
APA
Diniz, J. B., Shavitt, R. G., Fossaluza, V., Koran, L., Pereira, C. A. de B., & Miguel, E. C. (2011). A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 31( 6), 763-768. doi:10.1097/JCP.0b013e3182367aee -
NLM
Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA de B, Miguel EC. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder [Internet]. Journal of Clinical Psychopharmacology. 2011 ; 31( 6): 763-768.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1097/JCP.0b013e3182367aee -
Vancouver
Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA de B, Miguel EC. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder [Internet]. Journal of Clinical Psychopharmacology. 2011 ; 31( 6): 763-768.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1097/JCP.0b013e3182367aee - A double-blind randomized controlled trial of fluoxetine plus quetiapine or clomipramine vs. Fluoxetine plus placebo for obsessive-compulsive disorder
- Trajectory in obsessive-compulsive disorder comorbidities
- Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever
- Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns
- Validation of the University of Sao Paulo Sensory Phenomena Scale: Initial Psychometric Properties
- Perinatal risk factors and obsessive-compulsive spectrum disorders in patients with rheumatic fever
- Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
- Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial
- Comorbid major depression in obsessive-compulsive disorder patients
- Higher prevalence of obsessive-compulsive and related disorders in rheumatic fever
Informações sobre o DOI: 10.1097/JCP.0b013e3182367aee (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
